Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06638905

Efficacy and Safety of Skincare Serum and Cream for Anti-aging of Facial Skin

A Prospective, Open Label Clinical Study Evaluating the Efficacy and Safety of Skincare Serum and Cream for Anti-aging of Facial Skin

Status
Not Yet Recruiting
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
18 (estimated)
Sponsor
Goldman, Butterwick, Fitzpatrick and Groff · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The primary objective of this study is to assess the efficacy and safety of combination therapy of BABOR® Ultimate ECM Repair Serum and the BABOR® Cure Cream for the improvement of anti-aging through the use of investigator assessments, subject questionnaires/assessments, photography, skin imaging, and reported adverse reactions.

Detailed description

Enrolled subjects will use a skin care regimen cosisting of BABOR® Ultimate ECM Repair Serum, BABOR® Cure Cream gel, mineral sunscreen, and regeneration cleanser and regeneration toner. Subjects satisfying all inclusion and exclusion criteria will be enrolled in this trial. Prior to receiving any study treatment, mandatory photography using Canfield VISIA imaging and handheld 2D photography. Patients will return for follow-up assessments at Day 30, 60, and 90.

Conditions

Interventions

TypeNameDescription
DRUGBabor Ultimate ECM Repair SerumThe BABOR® Ultimate ECM Repair Serum contains Biogen plant extract, cotton thistle flower, and wakame extract. Babor products are encouraged to be used simultaneously mornings and/or evenings to reinforce the skin's protective barrier, promote vibrant skin, and restore skin elasticity and firmness.
DRUGBabor Cure CreamBabor products are encouraged to be used simultaneously mornings and/or evenings to reinforce the skin's protective barrier, promote vibrant skin, and restore skin elasticity and firmness.

Timeline

Start date
2024-10-28
Primary completion
2025-03-05
Completion
2025-05-05
First posted
2024-10-15
Last updated
2024-10-15

Source: ClinicalTrials.gov record NCT06638905. Inclusion in this directory is not an endorsement.